CompaniesCureMeta

CureMeta

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

1

As Collaborator

3

Total Enrollment

1,146

By Phase

NA: 3

By Status

RECRUITING: 2COMPLETED: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT06381024
NCT06371911
NCT06505018
Hover over trial bars to see details

Recent Trials

NCT06505018Collaborator
"Telemonitoring Platform CUREETY TECHCARE vs Standard of Care for mTBNC Patients Initiating a First-line Treatment"
NARecruiting
472 participants
Started: Jul 25, 2024 · Completed: Sep 2, 2028
NCT06371911Collaborator
Benefit of Adding Cureety TechCare Telemonitoring to Usual Care During Injectable Anticancer Treatment
NACompleted
192 participants
Started: Apr 3, 2024 · Completed: Aug 16, 2025
NCT06381024Collaborator
A Study of Telemonitoring in Cancer Patients
NARecruiting
82 participants
Started: Apr 4, 2023 · Completed: Dec 30, 2024
NCT05653609Lead Sponsor
Sensitivity and Specificity of the Clinical Classifications Generated by the Cureety Digital Telemonitoring Tool
N/ACompleted
400 participants
Started: Nov 15, 2022 · Completed: Dec 16, 2022